Seite - (000129) - in Biomedical Chemistry: Current Trends and Developments

Lal, R., Sukbuntherng, J., Luo, W., Huff, F.J., Zou, J., Cundy, K.C., (2010) The effect of food with varying fat content on the clinical pharmacokinetics of gabapentin after oral administration of gabapentin enacarbil. International Journal of Clinical Pharmacology and Therapeutics, 48(2), 120-128. Lal, R., Sukbuntherng, J., Luo, W., Tovera, J., Lassauzet, M.L., Cundy, K.C., (2013) Population Pharmacokinetics and Pharmacodynamics of Gabapentin After Administration of Gabapentin Enacarbil. Journal of Clinical Pharmacology, 53(1), 29-40. Lavé, T., Parrott, N., Grimm, H.P., Fleury, A., Reddy, M., (2007) Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica, 37(10-11), 1239-1310. Lee, K.S., Kim, S.K., (2011) Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug–drug interactions. Journal of Applied Toxicology, 33(2), 100-108. Li, C., Liu, B., Chang, J., Groessl, T., Zimmerman, M., He, Y.Q., Isbell, J., Tuntland, T., (2013) A modern in vivo pharmacokinetic paradigm: combining snapshot, rapid and full PK approaches to optimize and expedite early drug discovery. Drug Discovery Today. 18(1-2), 71- 78. Lindegardh, N., Tarning, J., Toi, P.V., Hien, T.T., Farrar, J., Singhasivanon, P., White, N.J., Ashton, M., Day, N.P., (2009) Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 49(3), 768-773. Lv, H., Zhang, X., Sharma, J., Reddy, M.V., Reddy, E.P., Gallo, J.M., (2013) Integrated Pharmacokinetic-Driven Approach to Screen Candidate Anticancer Drugs for Brain Tumor Chemotherapy. AAPS Journal, 15(1), 250-257. Mallet, C.R., Lu, Z., Fisk, R., Mazzeo, J.R., Neue, U.D., (2003) Performance of an ultra-low elution- volume 96-well plate: drug discovery and development applications. Rapid Communications in Mass Spectrometry, 17(2), 163-170. Marathe, P., Tang, Y., Sleczka, B., Rodrigues, D., Gavai, A., Wong, T., Christopher, L., Zhang, H., (2010) Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-690514, a Potent Inhibitor of EGFR and VEGFR2. Journal of Pharmaceutical Sciences, 99(8), 3579-3593. Mayr, L.M., Bojanic, D., (2009) Novel trends in high-throughput screening. Current Opinion in Pharmacology, 9(5), 580-588. Milton, M.N., Horvath, C.J. (2009) The EMEA Guideline on First-in-Human Clinical Trials and Its Impact on Pharmaceutical Development. Toxicologic Pathology, 37(3), 363-371. Murphy, A.T., Witcher, D.R., Luan, P., Wroblewski, V.J., (2007) Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood, 110(3), 1048-1054. Ninomiya, M., Tanaka, K., Tsuchida, Y., Muto, Y., Koketsu, M., Watanabe, K., (2011) Increased Bioavailability of Tricin-Amino Acid Derivatives via a Prodrug Approach. Journal of Medicinal Chemistry, 54(4), 1529-1536. Nishi, H., Nagamatsu, K. (2014) New trends in the LC separation analysis of pharmaceuticals – High performance separation by ultra-high-performance liquid chromatography (UHPLC) with core-shell particle C18 columns. Analytical Sciences, 30, 205-211. Ohlmeyer, M., Zhou, M.-M. (2010) Integration of Small-Molecule Discovery in Academic Biomedical Research. Mount Sinai Journal of Medicine, 77(4), 350-357.